Dr Reddy’s sale of proprietary drug brands underscores R&D challenges
Last week, Dr. Reddy’s Laboratories Ltd sold two neurology drug brands for $110 million and certain royalty payments that will be received in future. In April, too, the company had entered into a simi…
